(Q39163677)

9 September 2017

Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis (English)

1 reference

9 September 2017

propamidine isethionate

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

ChEBI ID

75283

Acanthamoeba keratitis

1 reference

2

Julia Walochnik

1 reference

9 September 2017

3

Andreas Obwaller

1 reference

9 September 2017

Zubeyde A Polat

1

1 reference

9 September 2017

Ayse Vural

series ordinal

4

1 reference

9 September 2017

Ayhan Dursun

series ordinal

5

1 reference

9 September 2017

Mustafa K Arici

series ordinal

6

1 reference

9 September 2017

21 May 2013

1 reference

Clinical and Experimental Ophthalmology

9 September 2017

1 reference

9 September 2017

42

1 reference

9 September 2017

2

1 reference

9 September 2017

151-158

1 reference

In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii

9 September 2017

1 reference

Pathogenic free-living amoebae: epidemiology and clinical review

21 January 2018

1 reference

Diagnosis and management of Acanthamoeba keratitis

21 January 2018

1 reference

21 January 2018

1 reference

Pathogenesis of acanthamoeba keratitis

21 January 2018

1 reference

Acanthamoeba keratitis: diagnosis and treatment update 2009.

21 January 2018

1 reference

Medical treatment for combined Fusarium and Acanthamoeba keratitis

21 January 2018

1 reference

Acanthamoeba keratitis--resistance to medical therapy.

21 January 2018

1 reference

Acanthamoeba keratitis: persistent organisms without inflammation after 1 year of topical chlorhexidine

21 January 2018

1 reference

Leishmania resistance to miltefosine associated with genetic marker

21 January 2018

1 reference

In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis

21 January 2018

1 reference

Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica

21 January 2018

1 reference

Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba

21 January 2018

1 reference

Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.

21 January 2018

1 reference

Anti-acanthamoeba efficacy and toxicity of miltefosine in an organotypic skin equivalent.

21 January 2018

1 reference

Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine

21 January 2018

1 reference

Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.

21 January 2018

1 reference

Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment

21 January 2018

1 reference

Effect of combined chlorhexidine gluconate and neosporin on experimental keratitis with two pathogenic strains of Acanthamoeba.

21 January 2018

1 reference

Advances in the diagnosis and treatment of acanthamoeba keratitis.

21 January 2018

1 reference

Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis

21 January 2018

1 reference

Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?

21 January 2018

1 reference

Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions

21 January 2018

1 reference

The pathophysiology of Acanthamoeba keratitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEO.12120

1 reference

9 September 2017

1 reference